PEOPLE - Metabolon makes appointment:
This article was originally published in Clinica
Metabolon (Durham, North Carolina), a firm specialising in the discovery of biomarkers for early diagnosis of disease states, has appointed Michael Milburn as chief scientific officer. Dr Milburn was formerly senior vice-president, research and corporate development, for pharma company Sirtris Pharmaceuticals. Metabolon analyses molecule groups through multiple mass spectrometry-based technologies, integrating and analysing the data through proprietary software and algorithms.